News AbbVie Inc.

Equities

ABBV

US00287Y1091

Real-time Estimate Cboe BZX Other stock markets 12:29:33 2024-04-26 pm EDT			5-day change	1st Jan Change
159.4 ^USD	-4.71%		-3.87%	+3.23%

06:27pm	Top Midday Stories: Google Announces First-Ever Dividend; Oil Giants Down on Earnings Misses; Second Norfolk Southern Union Backs Activist Investor's Board Candidates	MT
05:17pm	News Highlights : Top Company News of the Day - Friday at 11 AM ET	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Stories: Google Announces First-Ever Dividend; Oil Giants Down on Earnings Misses; Second Norfolk Southern Union Backs Activist Investor's Board Candidates	12:27pm	MT
News Highlights : Top Company News of the Day - Friday at 11 AM ET	11:17am	DJ
Sector Update: Health Care Stocks Mixed Premarket Friday	09:43am	MT
Well, it isn't as bad as feared...	09:16am
News Highlights : Top Company News of the Day - Friday at 9 AM ET	09:16am	DJ
Transcript : AbbVie Inc., Q1 2024 Earnings Call, Apr 26, 2024	09:00am
AbbVie raises annual targets	08:32am	CF
AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises	08:26am	DJ
AbbVie's Q1 Adjusted Earnings Fall, Net Revenue Rises; 2024 Adjusted Profit Outlook Lifted	08:10am	MT
Earnings Flash (ABBV) ABBVIE Reports Q1 Revenue $12.31B, vs. Street Est of $11.94B	07:54am	MT
Earnings Flash (ABBV) ABBVIE Reports Q1 EPS $2.31, vs. Street Est of $2.26	07:53am	MT
AbbVie: Q1 Earnings Snapshot	07:44am	AQ
AbbVie raises annual profit forecast on strong Skyrizi sales	07:36am	RE
Tech Strength Boosts Wall Street Pre-Bell; Asia, Europe Up	07:23am	MT
Stocks Rebound Pre-Bell Ahead of Pending Inflation Report; Asia, Europe Gain	07:20am	MT
North American Morning Briefing : Tech Still in -2-	06:26am	DJ
Futures climb as Alphabet, Microsoft results lift megacaps	06:00am	RE
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	Apr. 25	RE
AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint	Apr. 25	MT
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study	Apr. 25	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AbbVie Inc.

Equities

ABBV

US00287Y1091

Summary

Filters